Infiltration from CD8-positive T cells has been proposed as a biomarker able to differentiate acute liver failure of unknown causes from acute liver failure with known aetiology (e.g. drugs, metabolic disease, autoimmune process, and infections). The gene discussed is CD8A; the disease is acute liver failure.